[
  {
    "ts": "2026-02-23T15:56:49+00:00",
    "headline": "Here’s What Analysts Are Saying About IDEXX Laboratories (IDXX)",
    "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best pet stocks to buy according to hedge funds. On February 9, Piper Sandler cut the price target on IDEXX Laboratories, Inc. (NASDAQ:IDXX) to $750 from $775 while maintaining a Neutral rating on the shares. The rating update came after the company’s quarterly results, with the firm […]",
    "url": "https://finance.yahoo.com/news/analysts-saying-idexx-laboratories-idxx-155649759.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "1b685ebd-0252-3227-aeb8-8beba1c84e59",
      "content": {
        "id": "1b685ebd-0252-3227-aeb8-8beba1c84e59",
        "contentType": "STORY",
        "title": "Here’s What Analysts Are Saying About IDEXX Laboratories (IDXX)",
        "description": "",
        "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best pet stocks to buy according to hedge funds. On February 9, Piper Sandler cut the price target on IDEXX Laboratories, Inc. (NASDAQ:IDXX) to $750 from $775 while maintaining a Neutral rating on the shares. The rating update came after the company’s quarterly results, with the firm […]",
        "pubDate": "2026-02-23T15:56:49Z",
        "displayTime": "2026-02-23T15:56:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Jim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can't Get My Arms Around It”",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sd7C_hJ_TJUCWDWXLnDlaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QFqTatZh3Do84XbW2kldpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-saying-idexx-laboratories-idxx-155649759.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-saying-idexx-laboratories-idxx-155649759.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDXX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T20:48:56+00:00",
    "headline": "Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX)",
    "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 9, David Westenberg from Piper Sandler maintained his Overweight rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX). The analyst reduced the target price from $775 to $750, which results in a revised upside of 18%. Westenberg’s […]",
    "url": "https://finance.yahoo.com/news/reasons-why-hedge-funds-still-204856696.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c7b482c8-f61a-3e35-855b-188ba6630c11",
      "content": {
        "id": "c7b482c8-f61a-3e35-855b-188ba6630c11",
        "contentType": "STORY",
        "title": "Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX)",
        "description": "",
        "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 9, David Westenberg from Piper Sandler maintained his Overweight rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX). The analyst reduced the target price from $775 to $750, which results in a revised upside of 18%. Westenberg’s […]",
        "pubDate": "2026-02-23T20:48:56Z",
        "displayTime": "2026-02-23T20:48:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/0fd5962d64350d9f2f6231b1d20f9bbd",
          "originalWidth": 1280,
          "originalHeight": 820,
          "caption": "Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mMOC01Xhv3pGJpl6nwJC6g--~B/aD04MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/0fd5962d64350d9f2f6231b1d20f9bbd.cf.webp",
              "width": 1280,
              "height": 820,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TzHLA2YsRtXpkyhbxtGeMQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0fd5962d64350d9f2f6231b1d20f9bbd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reasons-why-hedge-funds-still-204856696.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reasons-why-hedge-funds-still-204856696.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDXX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]